No Photo Available

Last Update

2016-12-21T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong John Fallon?

Dr. John T. Fallon M.D. Ph.D.

Director of Laboratory Services

Westchester Medical Center

Direct Phone: (914) ***-****       

Email: j***@***.org

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Westchester Medical Center

100 Woods Rd.

Valhalla, New York 10595

United States

Company Description

Westchester Medical Center serves as a lifeline to the more than 3.5 million people in the Hudson Valley region and beyond. Well-known for its advanced medical care in trauma and burn, cardiovascular, cancer, transplant, neuroscience and pediatrics, commu ... more

Find other employees at this company (3,041)

Background Information

Employment History

Chairman of Pathology and Professor of Pathology and Medicine

New York Medical College

Professor of Pathology and Medicine

Mount Sinai School of Medicine

Member, Growing Amirsys Team

Amirsys , Inc.

Pathologist

Massachusetts General Hospital

Affiliations

Pathology Advisory Board Member
IMPAC Medical Systems , Inc.

Pathology Advisory Board Member
Tamtron Inc

Education

, MD PhD

M.D.

M.D.

New York Medical College

Web References (16 Total References)


"Depending on what mutations are ...

westfaironline.com [cached]

"Depending on what mutations are responsible for a person's tumor, there are specific medicines that can deal with tumors that have those mutations," said Dr. John Fallon, director of the department of clinical pathology at Westchester Medical Center in Valhalla.

The Philips software can build on existing lab and diagnostic equipment at the medical center to analyze the tissue of a tumor from a biopsy or other tests to search for specific genetic mutations. Patients' DNA can be tested for certain mutations known to cause cancer for which drug treatments are available. Those therapies are more directed at cancer cells and have less side effects than chemotherapy.
"Current chemotherapy, the big-league drugs that are used for tumors, kill everything," Fallon said. "They wipe out your hair, your GI tract, give you ulcers and all sorts of bad things."
With personalized treatments, "You are targeting your therapy for the tumor cells," Fallon said. "None of your normal cells are affected."
Fallon described genomics technology as in its "embryonic stage. Initially, the medical center will use genomic testing to search for 29 different types of mutations.
WMCHealth's use of the technology still must be approved by the state Department of Health, In the meantime, the medical center is focusing the new technology on research.
Fallon said this type of testing is typically only available at major urban hospitals or academic centers. He estimated that only 10 percent to 15 percent of patients in the country are able to access the testing. Patients in Westchester looking for genomic testing would have to travel to either Manhattan or Yale University in New Haven, he said.
Samples drawn from WMCHealth hospitals and health care service providers throughout the Hudson Valley can be brought to Westchester Medical Center for the same testing. "This keeps the patients in our system and close to home," Fallon said.
...
Fallon said genomics was first used by Westchester Medical Center in treating patients with cystic fibrosis. He described Westchester Medical Center as a major center for the genetic lung disease, as thousands of families have sought treatment at the hospital. Using genomics, patients can be tested for specific genetic mutations related to the disease and doctors can use that information to have treatments tailored to that mutation.
Fallon said genomics can also be used to track and identify different strains of infections, one of the main causes of death in hospitals. Westchester Medical Center can sequence the genome of every infectious bug it identifies.
"We know from genomic studies, we can trace in real time where they came from and we can do something about it," Fallon said.


Our new precision medicine platform for ...

www.clinicalomics.com [cached]

Our new precision medicine platform for oncology is designed to leverage all available sources of critical information to help make the most informed decisions about each patient's care," noted John Fallon, M.D., Ph.D., director, department of clinical pathology, Westchester Medical Center, and chairman of pathology, New York Medical College. "WMCHealth's new cancer diagnostic program gives us greater capabilities to test and validate clinical planning, through the fusion of highly specific and individualized patient information with massive and growing genomic knowledge of cancer."

According to Dr. Fallon, the Philips IntelliSpace Genomics solution is a foundation for designing possible therapy plans in a digital framework-such as how to match a tumor's genotype with a potential drug for the best outcome, or matching patients with clinical trials. "This is a powerful tool to help improve outcomes through precision medicine," he added, pointing out that the genomics project is part of a larger investment by WMCHealth into groundbreaking diagnostic and treatment capabilities, including WMCHealth's new cellular and tissue engineering laboratory-home to technology that facilitates cellular therapy under investigational new drug applications in support of treatments for a variety of hematological and oncological disorders and diseases.
The IntelliSpace Genomics solution can be configured to define new workflows, create new pipelines, or integrate new sources of data as required, and can be used for collaborative clinical analysis and sharing across multiple hospitals and their affiliates, either on-site or in the cloud, added Dr. Fallon.


Westchester Medical Center Launches Precision Medicine Initiative | GEN

www.genengnews.com [cached]

Our new precision medicine platform for oncology is designed to leverage all available sources of critical information to help make the most informed decisions about each patient's care," noted John Fallon, M.D., Ph.D., director, department of clinical pathology, Westchester Medical Center, and chairman of pathology, New York Medical College "WMCHealth's new cancer diagnostic program gives us greater capabilities to test and validate clinical planning, through the fusion of highly specific and individualized patient information with massive and growing genomic knowledge of cancer."

According to Dr. Fallon the Philips IntelliSpace Genomics solution is a foundation for designing possible therapy plans in a digital framework, such as how to match a tumor's genotype with a potential drug for the best outcome, for example, or matching patients with clinical trials. "This is a powerful tool to help improve outcomes through precision medicine," he added, pointing out that genomics project is part of a larger investment by WMCHealth into groundbreaking diagnostic and treatment capabilities, including WMCHealth's new cellular & tissue engineering laboratory, home to technology that facilitates cellular therapy under investigational new drug applications in support of treatments for a variety of hematological and oncological disorders and diseases.
The IntelliSpace Genomics solution can be configured to define new workflows, create new pipelines, or integrate new sources of data as required, and can be used for collaborative clinical analysis and sharing across multiple hospitals and their affiliates, either on-site or in the cloud, added Dr. Fallon.


John ("Jay") Fallon, M.D., PH.D. to lead Diagnostic Pathology CV team

www.amirsys.com [cached]

John ("Jay") Fallon, M.D., PH.D. to lead Diagnostic Pathology CV team

...
John ("Jay") Fallon, M.D., PH.D. to lead Diagnostic Pathology CV team
John ("Jay") T. Fallon, M.D., PH.D. has joined the growing Amirsys team of leading pathology experts as the Lead Author for the Amirsys Cardiovascular Pathology Team.Dr. Fallon also will serve as the Amirsys Anatomic Pathology Information Systems member on the Surgical Pathology Strategic Planning Committee.Dr. Fallon is a Professor of Pathology at the Mount Sinai School of Medicine.


Impac Software: The Elekta Group

www.impac.com [cached]

John Fallon, MD, The Mount Sinai Medical Center

Similar Profiles

Other People with this Name

Other people with the name Fallon

Mary Fallon
Catholic Education Commission

Chris Fallon
Tapestry Compliance LLP

Shannon Fallon
HopeHealth

George Fallon
RS&H Inc

Thomas Fallon
Omni Hotel

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory